z-logo
Premium
Optimal drug control in a four‐dimensional HIV infection model
Author(s) -
Shamsara Elham,
Afsharnezhad Zahra,
Effati Sohrab
Publication year - 2019
Publication title -
optimal control applications and methods
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.458
H-Index - 44
eISSN - 1099-1514
pISSN - 0143-2087
DOI - 10.1002/oca.2555
Subject(s) - hopf bifurcation , human immunodeficiency virus (hiv) , pontryagin's minimum principle , immunotherapy , immune system , optimal control , effector , drug , immunology , mathematics , virology , control theory (sociology) , biology , bifurcation , control (management) , computer science , mathematical optimization , physics , artificial intelligence , pharmacology , quantum mechanics , nonlinear system
Summary In this paper, we consider a four‐dimensional version of a human immunodeficiency virus (HIV) infection model, which is an extension of some previous three‐dimensional models. We approach the treatment problem by adding two controls u 1 and u 2 to the system for inhibiting viral production and preventing new infections. In fact, u 1 is added to components of uninfected and infected cells to represent the effect of chemotherapy on the interaction of uninfected CD4 + T cells with infected cells. u 2 is considered in the effector immune component as immunotherapy. The purpose of this work is to control the progress of the disease in a steady state. Hence, first, we obtain a relation between the two controls u 1 and u 2 such that a Hopf bifurcation occurs. Next, the Pontryagin minimum principle will be applied to derive the optimal therapy for HIV. At the end, numerical results are presented.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here